Apellis Pharmaceuticals shares owned by Lazard Asset Management
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Lazard Asset Management
from 13F filings
Historical chart of Lazard Asset Management investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Lazard Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $4.9M | 83k | 59.86 |
| 2023-09-30 | $4.4M | 116k | 38.04 |
| 2023-06-30 | $1.0M | 11k | 91.03 |
| 2023-03-31 | $2.3M | 35k | 65.94 |
| 2022-12-31 | $4.4M | 85k | 51.71 |
| 2022-09-30 | $3.1M | 46k | 68.29 |
| 2022-06-30 | $544k | 12k | 45.17 |
| 2022-03-31 | $136k | 2.7k | 50.69 |
| 2021-09-30 | $40k | 1.2k | 32.36 |
| 2021-03-31 | $56k | 1.3k | 42.30 |
| 2020-12-31 | $754k | 13k | 57.17 |
| 2019-09-30 | $1.3M | 53k | 24.08 |